22 January 2021 - In recognition of patients’ roles using, and contributing to, a publicly funded health system, the Canadian Agency for Drugs and Technologies in Health created a Patient and Community Advisory Committee. 

Twelve members bring lived experiences of chronic illness, progressive illness, mental illness, trauma, traveling long distances for treatment, and caregiving to an ill child, parent, or spouse. Members contribute their own insights and ideas but do not represent specific organisations or viewpoints. 

This paper explores how CADTH determined the committee's role, whether to have individuals or organisations as members, and how to recruit for diversity.

Read International Journal of Technology Assessment in Health Care article